{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:09:33Z","timestamp":1778886573029,"version":"3.51.4"},"reference-count":39,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0144","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:08:00Z","timestamp":1647346080000},"source":"Crossref","is-referenced-by-count":18,"title":["Chronic subdural hematoma\u2014antithrombotics and thrombotic complications"],"prefix":"10.3238","author":[{"given":"Hussam A.","family":"Hamou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Clusmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wiesmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertunc","family":"Altiok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"H\u00f6llig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"10.3238\/arztebl.m2022.0144_ref1","doi-asserted-by":"crossref","unstructured":"Rauhala M, Hel\u00e9n P, Huhtala H, et al.: Chronic subdural hematoma—incidence, complications, and financial impact. Acta Neurochir (Wien) 2020; 162: 2033–43.","DOI":"10.1007\/s00701-020-04398-3"},{"key":"10.3238\/arztebl.m2022.0144_ref2","doi-asserted-by":"crossref","unstructured":"Yang W, Huang J: Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017; 28: 205–10.","DOI":"10.1016\/j.nec.2016.11.002"},{"key":"10.3238\/arztebl.m2022.0144_ref3","doi-asserted-by":"crossref","unstructured":"Feghali J, Yang W, Huang J: Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 2020; 141: 339–45.","DOI":"10.1016\/j.wneu.2020.06.140"},{"key":"10.3238\/arztebl.m2022.0144_ref4","doi-asserted-by":"crossref","unstructured":"Aspegren OP, \u00c5strand R, Lundgren MI, Romner B: Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 2013; 115: 981–4.","DOI":"10.1016\/j.clineuro.2012.10.008"},{"key":"10.3238\/arztebl.m2022.0144_ref5","doi-asserted-by":"crossref","unstructured":"Rust T, Kiemer N, Erasmus A: Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 2006; 13: 823–7.","DOI":"10.1016\/j.jocn.2004.12.013"},{"key":"10.3238\/arztebl.m2022.0144_ref6","doi-asserted-by":"crossref","unstructured":"Bonis P de, Trevisi G, Waure C de, et al.: Antiplatelet\/anticoagulant agents and chronic subdural hematoma in the elderly. PLoS One 2013; 8: e68732.","DOI":"10.1371\/journal.pone.0068732"},{"key":"10.3238\/arztebl.m2022.0144_ref7","doi-asserted-by":"crossref","unstructured":"Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ: Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14: 108.","DOI":"10.1186\/s12974-017-0881-y"},{"key":"10.3238\/arztebl.m2022.0144_ref8","doi-asserted-by":"crossref","unstructured":"Yun HJ, Ding Y: How to remove those bloody collections: nonsurgical treatment options for chronic subdural hematoma. Brain Circ 2020; 6: 254–9.","DOI":"10.4103\/bc.bc_73_20"},{"key":"10.3238\/arztebl.m2022.0144_ref9","doi-asserted-by":"crossref","unstructured":"Sahyouni R, Goshtasbi K, Mahmoodi A, Tran DK, Chen JW: Chronic subdural hematoma: a historical and clinical perspective. World Neurosurg 2017; 108: 948–53.","DOI":"10.1016\/j.wneu.2017.09.064"},{"key":"10.3238\/arztebl.m2022.0144_ref10","doi-asserted-by":"crossref","unstructured":"Chen JC, Levy ML: Causes, epidemiology, and risk factors of chronic subdural hematoma. Neurosurg Clin N Am 2000; 11: 399–406.","DOI":"10.1016\/S1042-3680(18)30101-3"},{"key":"10.3238\/arztebl.m2022.0144_ref11","doi-asserted-by":"crossref","unstructured":"Gelabert-Gonz\u00e1lez M, Iglesias-Pais M, Garc\u00eda-Allut A, Mart\u00ednez-Rumbo R: Chronic subdural haematoma: surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 2005; 107: 223–9.","DOI":"10.1016\/j.clineuro.2004.09.015"},{"key":"10.3238\/arztebl.m2022.0144_ref12","doi-asserted-by":"crossref","unstructured":"Mehta V, Harward SC, Sankey EW, Nayar G, Codd PJ: Evidence based diagnosis and management of chronic subdural hematoma: A review of the literature. J Clin Neurosci 2018; 50: 7–15.","DOI":"10.1016\/j.jocn.2018.01.050"},{"key":"10.3238\/arztebl.m2022.0144_ref13","doi-asserted-by":"crossref","unstructured":"Link TW, Boddu S, Paine SM, Kamel H, Knopman J: Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases. Neurosurgery 2019; 85: 801–7.","DOI":"10.1093\/neuros\/nyy521"},{"key":"10.3238\/arztebl.m2022.0144_ref14","doi-asserted-by":"crossref","unstructured":"Dumont TM, Rughani AI, Goeckes T, Tranmer BI: Chronic subdural hematoma: a sentinel health event. World Neurosurg 2013; 80: 889–92.","DOI":"10.1016\/j.wneu.2012.06.026"},{"key":"10.3238\/arztebl.m2022.0144_ref15","doi-asserted-by":"crossref","unstructured":"Manickam A, La Marshman, Johnston R: Long-term survival after chronic subdural haematoma. J Clin Neurosci 2016; 34: 100–4.","DOI":"10.1016\/j.jocn.2016.05.026"},{"key":"10.3238\/arztebl.m2022.0144_ref16","doi-asserted-by":"crossref","unstructured":"Miranda LB, Braxton E, Hobbs J, Quigley MR: Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 2011; 114: 72–6.","DOI":"10.3171\/2010.8.JNS10298"},{"key":"10.3238\/arztebl.m2022.0144_ref17","doi-asserted-by":"crossref","unstructured":"Nathan S, Goodarzi Z, Jette N, Gallagher C, Holroyd-Leduc J: Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology 2017; 88: 1889–93.","DOI":"10.1212\/WNL.0000000000003918"},{"key":"10.3238\/arztebl.m2022.0144_ref18","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"10.3238\/arztebl.m2022.0144_ref19","doi-asserted-by":"crossref","unstructured":"Amano T, Matsuo S, Miyamatsu Y, Yamashita S, Nakamizo A: Impact of antithrombotic therapy on surgical treatment in patients with chronic subdural hematoma. J Clin Neurosci 2020; 74: 55–60.","DOI":"10.1016\/j.jocn.2020.01.076"},{"key":"10.3238\/arztebl.m2022.0144_ref20","doi-asserted-by":"crossref","unstructured":"Amano T, Takahara K, Maehara N, et al.: Optimal perioperative management of antithrombotic agents in patients with chronic subdural hematoma. Clin Neurol Neurosurg 2016; 151: 43–50.","DOI":"10.1016\/j.clineuro.2016.10.002"},{"key":"10.3238\/arztebl.m2022.0144_ref21","doi-asserted-by":"crossref","unstructured":"Dziedzic TA, Kunert P, Marchel A: Clinical course and results of surgery for chronic subdural hematomas in patients on drugs affecting hemostasis. J Korean Neurosurg Soc 2017; 60: 232–8.","DOI":"10.3340\/jkns.2015.1212.005"},{"key":"10.3238\/arztebl.m2022.0144_ref22","doi-asserted-by":"crossref","unstructured":"Fornebo I, Sj\u00e5vik K, Alibeck M, et al.: Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study. Acta Neurochir (Wien) 2017; 159: 2045–52.","DOI":"10.1007\/s00701-017-3330-x"},{"key":"10.3238\/arztebl.m2022.0144_ref23","doi-asserted-by":"crossref","unstructured":"Guha D, Coyne S, Macdonald RL: Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. J Neurosurg 2016; 124: 750–9.","DOI":"10.3171\/2015.2.JNS141889"},{"key":"10.3238\/arztebl.m2022.0144_ref24","doi-asserted-by":"crossref","unstructured":"Kamenova M, Lutz K, Schaedelin S, Fandino J, Mariani L, Soleman J: Does early resumption of low-dose aspirin after evacuation of chronic subdural hematoma with burr-hole drainage lead to higher recurrence rates? Neurosurgery 2016; 79: 715–21.","DOI":"10.1227\/NEU.0000000000001393"},{"key":"10.3238\/arztebl.m2022.0144_ref25","doi-asserted-by":"crossref","unstructured":"Kamenova M, Nevzati E, Lutz K, et al.: Burr-hole drainage for chronic subdural hematoma under low-dose acetylsalicylic acid: a comparative risk analysis study. World Neurosurg 2017; 100: 594–600.","DOI":"10.1016\/j.wneu.2017.01.065"},{"key":"10.3238\/arztebl.m2022.0144_ref26","unstructured":"Poon MTC, Rea C, Kolias AG, Brennan PM: Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma 2021; 38: 1177–84."},{"key":"10.3238\/arztebl.m2022.0144_ref27","doi-asserted-by":"crossref","unstructured":"Todeschi J, Ferracci F-X, Metayer T, et al.: Impact of discontinuation of antithrombotic therapy after surgery for chronic subdural hematoma. Neurochirurgie 2020; 66: 195–202.","DOI":"10.1016\/j.neuchi.2020.04.136"},{"key":"10.3238\/arztebl.m2022.0144_ref28","doi-asserted-by":"crossref","unstructured":"Zanaty M, Park BJ, Seaman SC, et al.: Predicting chronic subdural hematoma recurrence and stroke outcomes while withholding antiplatelet and anticoagulant agents. Front Neurol 2020; 10: 1401.","DOI":"10.3389\/fneur.2019.01401"},{"key":"10.3238\/arztebl.m2022.0144_ref29","doi-asserted-by":"crossref","unstructured":"Zhang P, Li Y, Huang J, et al.: Chronic subdural haematoma in antithrombotic cohorts: characteristics, surgical outcomes, and recurrence. Br J Neurosurg 2020; 34: 408–15.","DOI":"10.1080\/02688697.2020.1749987"},{"key":"10.3238\/arztebl.m2022.0144_ref30","doi-asserted-by":"crossref","unstructured":"Kan P, Maragkos GA, Srivatsan A, et al.: Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. Neurosurgery 2021; 88: 268–77.","DOI":"10.1093\/neuros\/nyaa432"},{"key":"10.3238\/arztebl.m2022.0144_ref31","doi-asserted-by":"crossref","unstructured":"Srivatsan A, Mohanty A, Nascimento FA, et al.: Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg 2019; 122: 613–9.","DOI":"10.1016\/j.wneu.2018.11.167"},{"key":"10.3238\/arztebl.m2022.0144_ref32","doi-asserted-by":"crossref","unstructured":"Murthy SB, Wu X, Diaz I, et al.: Non-traumatic subdural hemorrhage and risk of arterial ischemic events. Stroke 2020; 51: 1464–9.","DOI":"10.1161\/STROKEAHA.119.028510"},{"key":"10.3238\/arztebl.m2022.0144_ref33","doi-asserted-by":"crossref","unstructured":"Hemphill JC, Greenberg SM, Anderson CS, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 2015; 46: 2032–60.","DOI":"10.1161\/STR.0000000000000069"},{"key":"10.3238\/arztebl.m2022.0144_ref34","doi-asserted-by":"crossref","unstructured":"Chari A, Clemente MT, Rigamonti D: Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 2014; 28: 2–7.","DOI":"10.3109\/02688697.2013.812184"},{"key":"10.3238\/arztebl.m2022.0144_ref35","doi-asserted-by":"crossref","unstructured":"Phan K, Abi-Hanna D, Kerferd J, et al.: Resumption of antithrombotic agents in chronic subdural hematoma: a systematic review and meta-analysis. World Neurosurg 2018; 109: e792–e9.","DOI":"10.1016\/j.wneu.2017.10.091"},{"key":"10.3238\/arztebl.m2022.0144_ref36","doi-asserted-by":"crossref","unstructured":"Nassiri F, Hachem LD, Wang JZ, et al.: Reinitiation of anticoagulation after surgical evacuation of subdural hematomas. World Neurosurg 2020; 135: e616–e22.","DOI":"10.1016\/j.wneu.2019.12.080"},{"key":"10.3238\/arztebl.m2022.0144_ref37","doi-asserted-by":"crossref","unstructured":"Elm E von, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–7.","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"10.3238\/arztebl.m2022.0144_ref38","doi-asserted-by":"crossref","unstructured":"Markwalder TM: Chronic subdural hematomas: a review. J Neurosurg 1981; 54: 637–45.","DOI":"10.3171\/jns.1981.54.5.0637"},{"key":"10.3238\/arztebl.m2022.0144_ref39","doi-asserted-by":"crossref","unstructured":"Nof E, Kutyifa V, McNitt S, et al.: CHA2 DS2-VASc score and the risk of ventricular tachyarrhythmic events and mortality in MADIT-CRT. J Am Heart Assoc 2020; 9: e014353.","DOI":"10.1161\/JAHA.119.014353"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:08:28Z","timestamp":1647346108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0144","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]}}}